Mary Cushman, MD, MSc

 

Professor of Medicine and Pathology at the University of Vermont College of Medicine. She is a hematologist in the Department of Medicine at the University of Vermont Medical Center, where she is Director of the Thrombosis and Hemostasis Program. She is a Board Director of the University’s Cardiovascular Research Institute. 
She completed MD, residency and fellowship training at the University of Vermont and a Master of Science in Epidemiology at Harvard School of Public Health.

Dr. Cushman’s research interest is the study of causative factors for diseases of aging including heart disease, stroke, cognitive decline and venous thrombosis. Investigation of reasons for race/ethnic disparities are of particular interest.

Dr. Cushman is a Fellow of the American Heart Association (AHA) and American College of Physicians. She is a Board Director of the American Heart Association and serves on the AHA Science Advisory Coordinating Committee, and the American Society of Hematology Committee on Quality of Care. She is immediate past Chair of the AHA Council Operations Committee. She is a past Chair of the AHA Scientific Council on Epidemiology and Prevention and chaired the AHA Council on Epidemiology and Prevention’s 46th and 47th Annual Scientific Conferences.

Dr. Cushman is Senior Guest Editor of the journal Circulation and Associate Editor of the Journal of Thrombosis and Haemostasis.

She was awarded the Distinguished Academic Achievement Award from the University of Vermont College of Medicine in 2009, the Crystal Heart Award from the American Heart Association, Vermont Chapter, in 2011, the Senior Researcher of the Year Award from the UVM Medical Center in 2012 and the Distinguished Achievement Award from the Epidemiology and Prevention Council of AHA in 2014.

Dr. Cushman has authored 400 peer-reviewed publications and 36 invited reviews or chapters. Her work has been cited over 39,000 times by others. A publication list can be found at Cushman publications.


Peter Kouides, MD

 

Medical and Research Director, Mary M. Gooley Hemophilia Center Inc., Rochester, NY; Attending hematologist, Rochester General Hospital; Clinical Professor of Medicine, University of Rochester School of Medicine Clinical Associate Professor of Medicine, Roswell Park Memorial Cancer Institute 
Over the years, Peter Kouides, MD, has served as principal investigator on a number of studies primarily dealing with the gynecological and obstetrical complications of von Willebrand Disease (VWD) as well as thrombotic disorders of pregnancy. Dr. Kouides is also co-chair of the Centers for Disease (CDC) Universal Data Collection (UDC) study of women with bleeding disorders. He serves on the CDC UDC working group and is past co-chair of the International Society of Thrombosis and Hemostasis Women’s Hemostasis and Thrombosis Issues committee. He recently completed a textbook of bleeding disorders in women co-edited with Professors Christine Lee and Rezan Kadir. In 2005, Dr. Kouides received a National Hemophilia Foundation (NHF) Award of excellence for work in Women with bleeding disorders and then in 2009 the NHF Physician of the Year award. He was the 2010 recipient of the Rochester General Hospital Father Norton Physician of the Year award.

Dr. Kouides is also an appointed recent past member of the NHF Medical and Scientific Advisory Committee and recent past member of the U.S. Health and Human Services Advisory Committee on Blood Safety and Availability. He is a member of the Medical Advisory Committee for the Foundation for Women and Girls with Blood Disorders. He is immediate past-president of the Hemophilia and Thrombosis Research Society (HTRS) of North America. He is chair of the New England Hemophilia Treatment Centers Executive committee. He was co-chair of the first biennial Thrombosis and Hemostasis Summit of North America (THSNA) in 2012 and is co-chair for the 2014 meeting. Dr. Kouides is co-editor of NHF’s HemeAware magazine and the journal Seminars in Hemostasis and Thrombosis. He serves on the editorial board of Haemophilia. Dr. Kouides is the medical director of the Mary M. Gooley Hemophilia Treatment Center since 1998 and is also the team leader for the Mary M. Gooley Hemophilia Treatment Center World Federation of Haemophilia Twinning Program with Bishkek, Kyrgyzstan in setting up a National Haemophilia program and Treatment Center with visits in 2009, 2011, and 2013.

Stephanie Mann, MD

 

Assistant Professor at the University of Vermont College of Medicine in the Department of Obstetrics, Gynecology and Reproductive Sciences. 
She is boarded in Obstetrics and Gynecology as well as Maternal Fetal Medicine. Dr. Mann's career has been dedicated to Maternal Fetal Medicine as she takes care of pregnant women who have maternal or fetal complications. Dr. Mann's clinical expertise includes taking care of women with hematologic issues during their pregnancy. In addition to seeing patient's, Dr. Mann is the Director of University of Vermont's Ob/Gyn residency program and also devotes part of her time to investigating the impact of maternal obesity of vascular function. Dr. Mann has been honored as a top Maternal Fetal Medicine doctor (2012).